A hyaluronidase (CdtHya1) from Crotalus durissus terrificus snake venom (CdtV) was isolated and showed to exhibit a high activity on hyaluronan cleavage. However, surveys on this enzyme are still limited. This study aimed at its isolation, functional/structural characterization and the evaluation of its effect on the spreading of crotoxin and phospholipase A 2 (PLA 2 ). The enzyme was purified through cation exchange, gel filtration and hydrophobic chromatography. After that, it was submitted to a reverse-phase fast protein liquid chromatography (RP-FPLC) and Edman degradation sequencing, which showed the first Nterminal 44 amino acid residues whose sequence evidenced identity with other snake venom hyaluronidases. CdtHya1 is a monomeric glycoprotein of 64.5 kDa estimated by SDS-PAGE under reducing conditions. It exhibited maximum activity in the presence of 0.2 M NaCl, at 37 C, pH 5.5 and a specificity to hyaluronan higher than that to chondroitin-4-sulphate, chondroitin-6-sulphate or dermatan. Divalent cations (Ca 2þ and Mg 2þ ) and 1 M NaCl significantly reduced the enzyme activity. The specific activity of CdtHya1 was 5066 turbidity reducing units (TRU)/mg, against 145 TRU/mg for the soluble venom, representing a 34.9-fold purification. The pure enzyme increased the diffusion of crotoxin and PLA 2 through mice tissues. CdtHya1 (32 TRU/40 mL) potentiated crotoxin action, as evidenced by mice death, and it decreased the oedema caused by subplantar injections of buffer, crotoxin or PLA 2 , thus evidencing the relevance of hyaluronidase in the crotalic envenoming. This work yielded a highly active antiedematogenic hyaluronidase from CdtV, the first one isolated from rattlesnake venoms. Ó 2012 Elsevier Masson SAS.
Introduction
Snakebites related to the genus Crotalus are responsible for the highest levels of mortality described for ophidian accidents in Brazil [1] . Crotalus durissus terrificus venom (CdtV) shows neurotoxic, myotoxic and coagulant properties [2] , being the acute renal dysfunction the most serious complication of Crotalus snake bite [3] . Induction of systemic effects depends upon the toxins concentration and on their diffusion rate into the blood circulation to reach their site(s) of action [4] . Local tissue damage is also induced and is one of the most dramatic characteristics of viperid envenoming [5] , including necrosis, haemorrhage, oedema and extracellular matrix degradation [5, 6] . Since these problems reflect body spreading of venom toxins, the aim of this study was the isolation, functional and structural characterization of a hyaluronidase from CdtV.
Hyaluronidases (E.C. 3.2.1.35) have been reported as a constant component from snake venoms [4, 7] . These enzymes are known as "spreading factors" [4, 8] because they cleave hyaluronan, a nonproteoglycan polysaccharide found in the extracellular matrix (ECM), facilitating toxin diffusion into the tissues and blood circulation of the prey/victims [8e11]. Although they are not toxins [4, 10] , they indirectly potentiate the toxicity of venoms [4, 8] , contributing to local and systemic envenoming [11] and to the local tissue wrecking [12] . Furthermore, the envenomed victim may have a systemic collapse if circulating hyaluronan is degraded in the bloodstream [12] .
Their specific activities are quite variable among different species, even among those belonging to the same snake genus [11, 13] . A comparative study of the hyaluronidase activity of rattlesnake venoms showed that venom samples of Crotalus horridus horridus, Crotalus horridus atricaudatus, C. d. terrificus and Crotalus viridis viridis display very high hyaluronidase activity, while Crotalus ruber ruber and Sistrurus miliarius barbouri venom samples exhibited only trace amounts of this activity [14] .
In experimental studies, neutralization of hyaluronidase activity by monoclonal antibodies or some plant extracts inhibited tissue damage, the diffusion and the lethal effects of ophidian venoms [9,15e17] . Hyaluronidase inhibitors may be proteins, glycosaminoglycans, polysaccharides, fatty acids, lanostanoids, antibiotics, anti-nematodes, synthetic organic compounds, alkaloids, antioxidants, polyphenols, flavonoids, terpenoids or anti-inflammatory drugs [18] . It is probable that hyaluronidase inhibition would improve antivenom therapy by retarding toxins diffusion. In addition, the side effects of this therapy would be extenuated, since a lower dose would be effective for venom neutralization [19] . Furthermore, hyaluronidase has been used in various off-label clinical conditions to reduce tissue oedema, such as paraphimosis [20] , supraglottic airway oedema [21] and diabetic macular oedema [22] , as well as to facilitate reduction of intestinal intussusception [23] and after organ transplantation [24] .
However, in spite of the important role in ophidism, these enzymes have been practically ignored, as evidenced by the reduced number of published studies. Although there are about 400 venomous snakes known in the world among more than 3000 snake species (http://www.reptile-database.org) and hyaluronidases are ubiquitous in snake venoms [4, 7] , there are only a few studies on ophidian hyaluronidases isolated from Agkistrodon acutus [10] , Agkistrodon contortrix contortrix [13] , Naja naja [4] , Agkistrodon blomhoffii ussurensis [25] and Daboia russelli [26] venoms.
Given the limited information regarding hyaluronidases and the important role of these enzymes for understanding the mechanism of action of snake venoms, this study aimed at the isolation, functional and structural characterization of the enzyme from CdtV and the evaluation of its role as a spreading factor of crotoxin and PLA 2 .
Our study is the first one to isolate and characterize a rattlesnake hyaluronidase. The functional and structural characterization of CdtHya1 presented here may contribute to the optimization of therapies for ophidian accidents, and help in the understanding of the numerous pathophysiological processes in which the enzyme is involved. In this study, the effect of CdtHya1 on the edematogenic activity induced by crotoxin and PLA 2 isolated from CdtV was also investigated, since these toxins can induce or exacerbate inflammatory response [27] , producing paw oedema in rodent models [28] .
Material and methods

Material
Desiccated CdtV and male Swiss mice (28e32 g) were provided by Biotério Central (Universidade de São Paulo, Ribeirão Preto, SP, Brazil), in accordance with the guidelines of the Brazilian College for Animal Experimentation (COBEA) and Ibama, Brazilian Institute of Environment. Animal use was approved by the Committee for Ethics in Animals Utilization of Universidade de São Paulo (n 08.1.1038.53.1). Hyaluronan, chondroitin-4-sulphate, chondroitin-6-sulphate and dermatan were purchased from Sigma Chemical Co. (St. Louis, USA). CM-cellulose resin and HiPrep Sephacryl S-100 and HiTrap Phenyl-Sepharose columns were purchased from GE (Uppsala, Sweden). All other reagents used were of analytical grade.
Isolation of CdtHya1
Desiccated CdtV (1 g) was suspended in 50 mL of 0.05 M sodium acetate buffer, pH 5.5, centrifuged at 15,700Â g, 4 C, for 10 min, and applied on a CM-cellulose-52 column (1 Â 40 cm). Fractions were eluted using a step concentration gradient from 0 to 1.0 M NaCl in the same buffer, at a flow rate of 0.5 mL/min. Fractions of 2.0 mL/ tube were collected at 25 C. The sixth fraction, named CM6, was concentrated through a 30 kDa membrane on a model 8010 stirred ultrafiltration cell (Millipore Corp, Billerica, USA) and then filtered on a HiPrep Sephacryl S-100 (1.6 Â 60 cm) column previously equilibrated with 0.05 M sodium acetate buffer containing 0.15 M NaCl, pH 5.5. The second fraction, named S2, was applied to a HiTrap Phenyl-Sepharose column (1 mL, GE, Uppsala, Sweden) and the pure CdtHya1 was eluted using a linear concentration gradient from 1.0 to 0 M NaCl in a 0.05 M sodium acetate buffer, pH 5.5. Purity of the isolated hyaluronidase CdtHya1 was confirmed by reverse phase FPLC using a Shodex C4 column (0.46 Â 25 cm, Showa Denko KK, Kawasaki, Japan), eluting with a step concentration gradient from 0 to 100% of solvent B (60% acetonitrile, 0.1% trifluoroacetic acid), at a flow rate of 1.0 mL/min at room temperature. Absorbances (l ¼ 280 nm) were registered by FPLC Äkta Purifier UPC-10 system (GE, Uppsala, Sweden).
Hyaluronidase assay
Hyaluronidase activity was performed by a turbidimetric assay [11] adapted to microplate, with a 5-fold reduction of all reagents. To determine the optima conditions for hyaluronidase activity, venom and hyaluronan were incubated for 15 min at several pHs (2e11) and temperatures (0e80 C). Sodium acetate buffers (0.2 M) containing different concentrations of NaCl (0e1 M) or 0.2 M different salts (NaCl, KCl, CaCl 2 and MgCl 2 ) were employed to determine ion effects on the enzyme activity. The assay conditions producing maximum hyaluronidase activity were chosen for subsequent experiments. Turbidity reducing units (TRU) are expressed as the amount of enzyme required to hydrolyze 50% (5 mg) of hyaluronan; specific activity is turbidity-reducing units per mg of enzyme. Pessini et al. [29] determined that 0.153 TRU corresponds to 1 NFU (National Formulary Unit) according to Poh et al. [30] . Hyaluronidase activity on 0.5 mg/mL of different substrates (hyaluronan, chondroitin-4-sulphate, dermatan or chondroitin-6-sulphate) was evaluated under optimal conditions.
Kinetic studies
Kinetic studies were performed according to Poh et al. [30] . CdtHya1 (0.07 mg/mL) was incubated in 15 min under optima conditions with hyaluronan (5.4e432 mg/mL) or chondroitin-4-sulphate, chondroitin-6-sulphate or dermatan (5e50 mg/mL). The velocity of the reaction was expressed as micrograms of substrate hydrolyzed per millilitre per minute. K m and V max were determined by Prisma 6.0 software (GraphPad Software Inc., San Diego, USA).
Determination of proteins
Determination of total proteins was carried out according to the method described by Bradford [31] , using Bio-Rad Protein assay (Bio-Rad Laboratories, Inc., Berkeley, USA) and confirmed by 280/ 205 nm absorption method [32] . Bovine serum albumin (BSA) was used as standard.
SDS-PAGE
SDS-PAGE (10%) containing hyaluronan was run. After electrophoresis, part of the gel was stained with Stains-all (Sigma Chemical Co., St. Louis, USA) for evaluation of the hyaluronidase activity [33] , and the remaining with PlusOne Coomassie Blue PhastGelÔ R-350 (GE Healthcare, Uppsala, Sweden). SDS-PAGE (10%) was carried out according to Laemmli [34] ; after that, periodic acid-Schiff (PAS) staining was used to detect glycoproteins [35] .
CdtHya1 sequencing
The sequence of hyaluronidase CdtHya1 was determined by Edman degradation [36] , performed on an automated sequenator model PPSQ-33A (Shimadzu Co., Kyoto, Japan). The identity of thus primary sequence compared with those of other proteins was searched by using BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi). The amino acid sequences of snake venom hyaluronidases were retrieved from the Universal Protein Resource Knowledgebase (www.uniprot.org). The alignment was created by MultAlin Interface Page [37] and the figure was generated by ESPript [38] server.
Paw oedema
Paw oedema was induced in male Swiss mice (28e32 g) by subplantar injection of buffer containing crotoxin or PLA 2 with or without hyaluronidase CdtHya1, in the right hind paw. The volume of the paw was measured with a paquimeter (Mitutoyo, Kawasaki, Japan) before and after toxin injections at different intervals of time (n ¼ 5). The data (mean AE standard error of the mean) were analyzed by one-way ANOVA followed by Tukey's test (p < 0.05 was considered statistically significant).
Results
Isolation of CdtHya1
CdtHya1 was purified by three chromatographic steps: cation exchange, gel filtration and hydrophobic chromatography.
The crude soluble venom of C. d. terrificus, when applied on a CM-cellulose-52 column, showed nine fractions, named "CM1" to "CM9" (Fig. 1A) . Hyaluronidase activity was detected in fractions "CM5" and "CM6" (vertical bars, Fig. 1A ). In this study, only fraction "CM6" was used, because it has shown higher hyaluronidase activity. Around 12.4% of the total activity was recovered, from which 0.99% in fraction "CM6". This fraction was subjected to a Sephacryl S-100 molecular sieve chromatography and four subfractions were obtained. Hyaluronidase was detected in fraction S2 (Fig. 1B) . Pure hyaluronidase was isolated by rechromatographing fraction S2 on a Phenyl-Sepharose column and it was named CdtHya1 (Fig. 1C) . It has a specific activity 34.9 times higher than that of the crude soluble venom and represents 8.2% of the total activity and 0.23% of the total protein (Table 1) . Afterwards, the purity degree of CdtHya1 was checked by reverse-phase FPLC on a C4 column, disclosing a single peak (Fig. 1D ).
Hyaluronidase activity and kinetic assays
Reducing SDS-PAGE indicated that CdtHya1 presents a single band of about 64.5 kDa. Under non-reducing conditions, it shows a single polypeptide chain of about 74.1 kDa which corresponds to the translucent band against the dark blue background in the gel with hyaluronan ( Fig. 2A) . The enzyme is a glycoprotein, as evidenced by PAS staining (Fig. 2B, lane 4) .
CdtHya1 is active within the pH range from 4 to 7, with an optimum pH of 5.5 (Fig. 3A) . It is active between 10 and 50 C with optimal activity at 37 C (Fig. 3B) . The enzyme was stable for 30 days in the purification buffer at 7 C and still active for more than 60 days under the same conditions. Hyaluronidase was isolated using a concentration gradient of NaCl (0e1 M) and its activity was greatly influenced by sodium chloride. At concentrations above 0.3 M, NaCl can induce a false positive hyaluronidase activity (control data not shown) and maximum activity is observed in the presence of 0.2 M NaCl (Fig. 3C) . Divalent cations (Ca 2þ and Mg 2þ ) and 1 M NaCl significantly reduced the enzyme activity ( Fig. 3D and  C, respectively) . Furthermore, CdtHya1 exhibited higher activity on hyaluronan than on chondroitin-4-sulphate, chondroitin-6-sulphate or dermatan (Fig. 3E) .
It was observed by K cat that CdtHya1 hydrolyzes about 10 times more hyaluronan than chondroitin-4-sulphate, chondroitin-6-sulphate or dermatan (Table 2 ). However, CdtHya1 shows from 5.3 to 6.9 times higher affinity to these three later substrates than to hyaluronan, as evidenced by K m . Afterwards, the enzyme presents a catalytic efficiency about 1.7 times greater to hydrolyze hyaluronan than to cleavage chondroitin-4-sulphate, chondroitin-6-sulphate or dermatan and its catalytic efficiency is the same for these three later tested substrates (Table 2 ).
Antiedematogenic activity
Oedema peak reached a maximum at 30 min for almost all the injected solutions (Fig. 4) . Crotoxin and PLA 2 groups induced a significant increase in the volume of the paw of the animal when compared to control (p < 0.001). The association of pure hyaluronidase to PLA 2 caused a delay in the time of maximum oedema peak and reduction of the oedema induced by PLA 2 , crotoxin or buffer. The reduction of oedema caused by hyaluronidase dissolved in buffer was significant (p < 0.01) after 30 min, when compared to the control. At 340 min, it was observed a significant oedema only in the groups crotoxin and crotoxin þ hyaluronidase (p < 0.01).
Initial N-terminal and in silico studies
The first 44 N-terminal amino acids from CdtHya1 were determined as MQAKAPMYPNEPFLVFWNAPTTQCRLRYKVDLDLNTFHIV-TNAR. This primary sequence will appear in the UniProt Knowledgebase under the accession number B3EWP2 and showed identity with other hyaluronidases sequences deposited in data banks (Fig. 5) .
Residue Glu135, which participates in the catalytic mechanism, is conserved in the sequences of the aligned snake hyaluronidases. Residues Asp133, Tyr206, Tyr253 and Trp328 are essential for the positioning of the substrate's carbonyl of the acetamido group for catalysis and are conserved among vertebrate hyaluronidases [39] . The cysteine scaffold is also conserved among these sequences hyaluronidases: Cys47, Cys340, Cys211, Cys227, Cys365, Cys370, Cys376 and Cys429 [12] .
Discussion
The purification procedure of the hyaluronidase from CdtV by three chromatographic steps (protein recovery ¼ 0.23%) was able to provide a highly active enzyme. SDS-PAGE under reducing and nonreducing conditions, reversed phase FPLC and N-terminal sequencing analysis confirmed the high degree of purity of the enzyme. The specific activity for the soluble venom was 145 turbidity reducing units (TRU)/mg against 5066 TRU/mg for pure hyaluronidase, representing a 34.9-fold purification.
Hyaluronidase CdtHya1 is a monomeric glycoprotein of 64.5 kDa, as estimated by SDS-PAGE under reducing conditions. Most venom hyaluronidases related in earlier reports are monomeric proteins [10,11,26,29,40e42 ]. The observed molar mass is within the range of 50e70 kDa described for hyaluronidases from viperid and elapid snake venoms [4, 12, 13, 33] .
CdtHya1 showed a maximum activity at pH 5.5 and its activity decreased by half at pH 6.5 and it was virtually abolished at pH 7.0. Hyaluronidases from snake, bee, scorpion and lizard venoms are optimally active in vitro in a pH range from 4.0 to 6.0 [4, 8, 10, 13, 26, 29, 30, 41, 43] . Generally, hyaluronidases are classified as acid active (active between pH 3 and 4) or neutral active (active between pH 5 and 6) [44, 45] . Being optimally active at pH 5.5, CdtHya1 belongs to the later class. Interestingly, several components of snake venoms induce the releasing of mediators which promote local inflammation [46e48] and the inflammatory exudates generated cause decrease in pH, usually between 6.9 and 6.0 [49] . In addition, many snake bites are to the skin and subcutaneous tissue [48] , where pH is slightly acidic [50] . At these acidic conditions, hyaluronidase activity is maximal, thus occurring the local tissue injury and systemic distribution of venom components by the enzyme.
CdtHya1 exhibited a maximal activity at 37 C and it was completely denatured above 60 C. Other snake venom hyaluronidases lose their native conformation by heating at 60 C [4, 13, 51] . Hyaluronidases show considerable variation in thermal stability. Some preparations rapidly lose their activity when stored above 4 C [8] while others are stable and maintain the enzyme activity at room temperature for several days [52] . Hyaluronidase from Vipera russelli siamensis venom lost 15% of activity after 2 weeks storage in a solution at 4 C [11] and the enzyme from N. naja remained stable for over 15 days at 37 C [4] . In this work it was detected about 60% reduction in activity of CdtHya1 stored in acetate buffer, pH 5.5, for 60 days at À20 C and it was active after storage for several months at 4 C, although degradation bands by SDS-PAGE (data not shown) have been detected. Although CdtHya1 has partially degraded chondroitin-4-sulphate, chondroitin-6-sulphate and dermatan, its higher A kinetic study was carried out using 5.4e432 mg/mL hyaluronan or 5e50 mg/mL chondroitin-4-sulphate (C4S), chondroitin-6-sulphate (C6S), or dermatan as substrates. After 15 min of incubation at 37 C, the amounts of hydrolyzed substrate were determined by a turbidimetric assay. Data were obtained from one representative experiment. Kinetic constants were calculated by fitting the data to the MichaeliseMenten equation using a non-linear regression in Prism (GraphPad Software). activity on hyaluronan was evident. Interestingly CdtHya1 presented the lowest affinity (higher K m ) and the highest hydrolysis rate on hyaluronan, when compared on chondroitin-4-sulphate, chondroitin-6-sulphate or dermatan. It is speculated that this outstanding result is due to differences in polymer sizes and isomeric patterns. Hyaluronan has a molar mass between 3 Â 10 6 and 5.8 Â 10 6 , while the other tested substrates have a molar mass in the range of 1 Â 10 4 e4 Â 10 4 (Sigma's technical information).
Since hyaluronan is far greater than the other substrates, it presents a higher number of repeating units of N-acetyl-D-glucosamine and D-glucuronic acid to be cleaved, thus facilitating the access of hyaluronidase to the hydrolysis sites. Another difference is that hyaluronan is formed by N-acetyl-D-glucosamine, while the other tested substrates are formed by N-acetyl-D-galactosaminesulphate. Snake venom hyaluronidases (EC 3.2.1.35) degrade hyaluronan, chondroitin, chondroitin-4-sulphate and chondroitin-6-sulphate, producing mainly tetrasaccharides [53] . In contrast, hyaluronidases from N. naja [4] and A. c. contortrix [13] venoms exhibited absolute specificity to hyaluronan whereas bovine testicular hyaluronidase cleaved various glycosaminoglycans tested, including hyaluronan, chondroitin, chondroitin-4-sulphate, chondroitin-6-sulphate, chondroitin sulphate D and chitosans of high, medium and low molar mass [4] . The turbidimetric method for hyaluronidase assay is very dependent upon salt concentration [54, 55] . So it is necessary to establish conditions of salt concentration under which such assays can be carried out with the least possible interference from salt effects [56, 57] . Regarding negative control, as salt concentration increases, there is a marked drop in turbidity. These values should be discounted from those regarding the active fractions eluted with a concentration gradient of NaCl (0e1 M) in the chromatographic steps to avoid a false positive activity. Maximum hydrolysis was achieved with 0.2 M NaCl. Up to 0.3 M, there is little interference of NaCl in the reduction of the turbidity of hyaluronan and the activity is abolished with 1 M NaCl. Further experiments were carried out using other 0.2 M salts. Na þ and K þ , enhanced the hyaluronidase activity while divalent cations, Mg 2þ and Ca 2þ , inhibited the enzyme activity. Similar results were observed for hyaluronidase from funnel web spider in the presence of 0.3 M salts, when monovalent cations enhanced the activity and divalent cations were found to be inhibitory [56] . Hyaluronidase from A. c. contortrix also showed maximum activity in the presence of 0.2 M NaCl [13] . The hyaluronidase activity from N. naja was maximal in the presence of 0.15 M NaCl and inhibited at concentrations above 0.5 M NaCl [4] . Pure CdtHya1 increased the diffusion of crotoxin and PLA 2 through mice tissues. The mice injected with crotoxin plus hyaluronidase exhibited spasm and motor difficulties 180 min after subplantar injection. Two animals had died 330 min after injection, and all animals in this group were dead the day after the test. However, no animal injected with crotoxin, without the enzyme, died. CdtHya1 acted as "spreading factor" of the toxin, increasing its absorption rate by the tissues and causing greater damage to the organism. It is worth to note that the animals of the other five groups were normal throughout the test and the next day. So hyaluronidase inhibition can contribute for minimizing local tissue damage and the systemic distribution of venom as determined in other studies [58] . Besides acting as a spreading factor, CdtHya1 has antiedematogenic activity. Mice injected with crotoxin showed almost 80% of oedema paw, while it was observed almost 40% of oedema paw when CdtHya1 was associated to crotoxin, compared to the control in 30 min. It also was effective in accelerating the dispersion of buffer in the tissues. In 340 min, the paw thickness of animals injected with hyaluronidase plus PLA 2 returned to baseline values, while in animals injected with crotoxin and crotoxin plus hyaluronidase the oedema persisted. These results support the conviction that crotoxin complex is more toxic than pure PLA 2 , as reported in the literature [59e61]. The antiedematogenic activity is probably due to substrate hydrolysis, since hyaluronan possesses strong water-binding capacity [24] and its massive accumulation has been documented in oedema [62] . It was also reported that hyaluronidase did not cause oedema formation and did not induce an increase in lung vascular permeability, ameliorating pulmonary fibrosis by mesenchymal-like cells recruitment [63] .
The sequence of the first 44 amino acids of the N-terminal region of CdtHya1 showed identity with those of other hyaluronidase sequences previously deposited of other species of snakes belonging to the same Viperidae family. These primary sequences were aligned to determine the amino acid residues conserved among these snake hyaluronidases. CdtHya1 shows a high sequence identity with hyaluronidases obtained by transcriptome from Bitis arietans, Cerastes cerastes, Echis pyramidum, Echis ocellatus, non-conservative substitutions being observed only in a few positions. These snake hyaluronidases present a high level of sequence identity (>95%) and retain all the catalytic, positional and structural residues that characterize this class of enzyme [12] . The signal peptides of these sequences were reported as being from residues 1 to 20 [12] . However, alignment with CdtHya1, whose sequence was obtained from the pure enzyme which is secreted by the snake venom gland, suggests that residues 21e23 are also part of the signal peptide.
The purification, structural and biological characterization of bioactive molecules lead to the development of new research tools, diagnostic reagents and therapeutic drugs [64, 65] . New biomolecules isolated from venomous animals present great potential for medical applications [64e69] and they are expected to be used in the development of antivenoms. Though proved to be efficient, the systemically administered antivenoms have minimal protective effect on local tissue necrosis. Therefore, hyaluronidases should be considered as potential targets for a better snake bite treatment. Inhibitors of locally acting hyaluronidases not only reduced local tissue damage but also reduced the magnitude of systemic effects [9] . In experimental studies, neutralization of hyaluronidase by monoclonal antibodies or derivatives from plants inhibited tissue damage, the diffusion and the lethal effects of ophidian venoms [9,15e17] .
Although the amount of the enzyme in snake venoms is low, hyaluronidases from venoms are very active, potentiate the toxicity of the venom [4, 8] and can cause systemic collapse of the victim due to extensive degradation of hyaluronan [12] . Therefore, this study on the characterization of hyaluronidase from C. d. terrificus snake venom may contribute to the optimization of therapies for these accidents, and help in the understanding of the numerous pathophysiological processes in which the enzyme is involved. CdtHya1 also presented antiedematogenic activity. Thus, it could be used therapeutically to reduce oedema.
Conclusions
In conclusion, despite the fact that the purification procedure of hyaluronidase CdtHya1 from C. d. terrificus venom is relatively simple, it was able to afford the first rattlesnake hyaluronidase with high antiedematogenic activity.
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